J. Pérez-Gracia

Streamlining clinical research: An ESMO awareness call to improve Sponsoring and Monitoring of Clinical Trials.

V. Grünwald, T. Amaral, M. Lolkema, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

J. Prieto, B. Sangro, I. Melero, 2013, Journal of hepatology.

Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial

M. Burotto, A. Armstrong, L. Lacombe, 2022, Journal for ImmunoTherapy of Cancer.

Dendritic Cells in Cancer Immunology and Immunotherapy

S. Inogés, L. Hato, I. Eguren, 2024, Cancers.

CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

J. Zapata, I. Melero, P. Berraondo, 2023, Science advances.

Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL‐8

K. Schalper, I. Melero, M. Rodriguez-Ruiz, 2021, The Journal of pathology.

Clinical Development of Immunostimulatory Monoclonal Antibodies and Opportunities for Combination

P. Ascierto, I. Melero, A. Grimaldi, 2013, Clinical Cancer Research.

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

I. Melero, M. Rodriguez-Ruiz, P. López-Casas, 2019, Journal of Immunotherapy for Cancer.

Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps

M. Rodriguez-Ruiz, P. Berraondo, Á. Teijeira, 2024, Clinical cancer research : an official journal of the American Association for Cancer Research.

In vivo depletion of DC impairs the anti‐tumor effect of agonistic anti‐CD137 mAb

I. Melero, P. Berraondo, A. Arina, 2009, European journal of immunology.

Synergistic effects of CTLA‐4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo

B. Sangro, I. Melero, F. Lecanda, 2011, International Journal of Cancer.